Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1380000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 22nd Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
発行・処分する株式数
Number of shares delivered during the month: 1,380,000 shares (1,380,000 new shares and 0 treasury shares transferred)
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
発行済株式総数
Exercise ratio subject to the exercise restriction: 3.0% (1,380,000 shares / 45,593,560 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the month: ¥27.00, ¥28.00 or ¥29.00 (details of the adjustment clause and the floor are not disclosed)
Number of Stock Acquisition Rights
Total number issued: 210,000; unexercised as of the end of the month preceding the relevant month: 121,710; unexercised as of the end of the relevant month: 107,910
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
13 May 2026: Issuance of the 22nd Stock Acquisition Rights, with EVO FUND as the allottee, through a third-party allotment (total number issued: 210,000)
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 22nd Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | Number of shares delivered during the month: 1,380,000 shares (1,380,000 new shares and 0 treasury shares transferred) |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | Exercise ratio subject to the exercise restriction: 3.0% (1,380,000 shares / 45,593,560 shares) |
| Total number of issued shares | 54,422,560 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | Exercise prices during the month: ¥27.00, ¥28.00 or ¥29.00 (details of the adjustment clause and the floor are not disclosed) |
| Number of Stock Acquisition Rights | Total number issued: 210,000; unexercised as of the end of the month preceding the relevant month: 121,710; unexercised as of the end of the relevant month: 107,910 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | 13 May 2026: Issuance of the 22nd Stock Acquisition Rights, with EVO FUND as the allottee, through a third-party allotment (total number issued: 210,000) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is a report on the monthly exercise status, and the company has provided no explanation of the reasons for the exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.